Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
MRKR Marker Therapeutics
0.321
+0.014+4.56%
Post Mkt Price
0.326
+0.004+1.34%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Assets
Current assets
Cash, cash equivalents and short term investments
-62.89% 18.08M -54.87% 25.82M -55.61% 28.64M 98.34% 42.35M
-Cash and cash equivalents
-62.89% 18.08M -54.87% 25.82M -55.61% 28.64M 98.34% 42.35M
Receivables
691,677.37% 1.68M 219,350.70% 627.63K -99.78% 2.19K -99.98% 237
-Other receivables
691,677.37% 1.68M 219,350.70% 627.63K -99.78% 2.19K -99.98% 237
Prepaid assets
-1.32% 2.67M 0.89% 2.83M 11.89% 2.2M 20.73% 2.48M
Restricted cash
-- 0 -- 0 -- 181.86K -- 1.15M
Total current assets
-56.38% 22.42M -51.23% 29.28M -54.03% 31.02M 88.37% 45.98M
Non current assets
Net PPE
-8.97% 18.69M 12.69% 23.04M 14.59% 23.94M 4.47% 22.15M
-Gross PPE
2.88% 23.36M 22.05% 26.94M 23.97% 27.25M 14.21% 24.89M
-Accumulated depreciation
-114.76% -4.67M -139.90% -3.9M -203.11% -3.32M -363.62% -2.74M
Total non current assets
-8.97% 18.69M 12.69% 23.04M 14.59% 23.94M 4.47% 22.15M
Total assets
-42.85% 41.11M -34.98% 52.32M -37.81% 54.96M 49.37% 68.14M
Liabilities
Current liabilities
Payables
-13.11% 2.02M -13.47% 1.77M 165.68% 5.02M 75.26% 5.14M
-accounts payable
-13.11% 2.02M -13.47% 1.77M 165.68% 5.02M 75.26% 5.14M
Current accrued expenses
-63.15% 1.42M -28.20% 1.4M 65.38% 1.59M 184.39% 3.94M
Current debt and capital lease obligation
-15.67% 490.45K 32.17% 738.39K 44.58% 683.97K 59.59% 620.49K
-Current capital lease obligation
-15.67% 490.45K 32.17% 738.39K 44.58% 683.97K 59.59% 620.49K
Current deferred liabilities
-- 5.05M -- 8M -- 181.86K -- 1.15M
Other current liabilities
40.77% 404 540.35% 251 -223.55% -320 -970.00% -87
Current liabilities
37.19% 11.29M 138.07% 13.47M 98.07% 8.21M 101.53% 12.9M
Non current liabilities
Long term debt and capital lease obligation
-36.79% 7.23M -6.47% 10.82M -5.84% 11.04M -5.23% 11.25M
-Long term capital lease obligation
-36.79% 7.23M -6.47% 10.82M -5.84% 11.04M -5.23% 11.25M
Total non current liabilities
-36.79% 7.23M -6.47% 10.82M -5.84% 11.04M -5.23% 11.25M
Total liabilities
-5.82% 18.51M 41.01% 24.29M 21.32% 19.25M 32.18% 24.15M
Shareholders'equity
Share capital
0.63% 83.6K 0.63% 83.6K 0.53% 83.45K 63.76% 83.08K
-common stock
0.63% 83.6K 0.63% 83.6K 0.53% 83.45K 63.76% 83.08K
-Preferred stock
-- 0 -- 0 -- 0 -- --
Retained earnings
-9.23% -424.19M -11.00% -417.27M -11.78% -408.03M -11.76% -398.12M
Paid-in capital
1.40% 446.71M 1.40% 445.22M 1.42% 443.65M 15.25% 442.02M
Total stockholders'equity
-56.77% 22.6M -55.69% 28.03M -50.75% 35.71M 60.86% 43.99M
Total equity
-56.77% 22.6M -55.69% 28.03M -50.75% 35.71M 60.86% 43.99M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEO: Mr. Peter L. Hoang
Market: NASDAQ
Listing Date: 11/07/2016
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist